Alignment Healthcare (NASDAQ:ALHC) Stock Price Down 9%

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) shares were down 9% during mid-day trading on Tuesday . The company traded as low as $10.71 and last traded at $10.76. Approximately 320,465 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 951,762 shares. The stock had previously closed at $11.82.

Wall Street Analysts Forecast Growth

ALHC has been the topic of a number of research analyst reports. Robert W. Baird increased their price target on Alignment Healthcare from $10.00 to $11.00 and gave the company an "outperform" rating in a research note on Wednesday, August 14th. TD Cowen increased their price objective on shares of Alignment Healthcare from $8.00 to $10.00 and gave the company a "buy" rating in a research report on Tuesday, August 6th. Barclays raised their target price on shares of Alignment Healthcare from $4.50 to $7.00 and gave the stock an "underweight" rating in a research note on Monday, August 5th. Piper Sandler reiterated an "overweight" rating and issued a $10.00 price target (up previously from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. Finally, Stifel Nicolaus raised their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a "buy" rating in a research report on Friday, July 26th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $9.83.

Alignment Healthcare Stock Down 16.1 %

The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.70. The firm has a market cap of $1.90 billion, a price-to-earnings ratio of -12.42 and a beta of 1.43. The firm's 50 day simple moving average is $9.65 and its two-hundred day simple moving average is $7.75.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.01. The company had revenue of $681.29 million during the quarter, compared to the consensus estimate of $637.66 million. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 101.10%. The firm's quarterly revenue was up 47.3% on a year-over-year basis. During the same period in the previous year, the business earned ($0.15) earnings per share. On average, equities analysts forecast that Alignment Healthcare, Inc. will post -0.67 EPS for the current year.

Insider Activity

In other news, CFO Robert Thomas Freeman sold 14,500 shares of the stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.00, for a total transaction of $174,000.00. Following the sale, the chief financial officer now directly owns 264,429 shares of the company's stock, valued at approximately $3,173,148. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CFO Robert Thomas Freeman sold 14,500 shares of the company's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.00, for a total transaction of $174,000.00. Following the completion of the sale, the chief financial officer now owns 264,429 shares of the company's stock, valued at approximately $3,173,148. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Dawn Christine Maroney sold 36,700 shares of the stock in a transaction that occurred on Friday, July 19th. The stock was sold at an average price of $10.01, for a total transaction of $367,367.00. Following the sale, the insider now owns 1,816,097 shares in the company, valued at approximately $18,179,130.97. The disclosure for this sale can be found here. In the last three months, insiders sold 267,973 shares of company stock worth $2,671,391. 6.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors have recently modified their holdings of the business. Virtu Financial LLC bought a new position in Alignment Healthcare in the first quarter valued at about $57,000. Principal Financial Group Inc. bought a new stake in shares of Alignment Healthcare during the 1st quarter valued at approximately $57,000. Mackenzie Financial Corp increased its position in Alignment Healthcare by 110.0% during the 2nd quarter. Mackenzie Financial Corp now owns 36,526 shares of the company's stock worth $286,000 after purchasing an additional 19,129 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in Alignment Healthcare by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company's stock worth $196,000 after purchasing an additional 3,334 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in Alignment Healthcare by 20.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company's stock valued at $434,000 after purchasing an additional 9,595 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.